60 Stock and 40 ETF Syndax Pharmaceuticals (SNDX) alternatives
The most close Syndax Pharmaceuticals (SNDX) alternative is company Jefferson Capital (JCAP). The correlation is 0.666.
Stocks that highly correlated with SNDX
| Symbol | Name | Market cap | Sector | Industry | Correlation |
|---|---|---|---|---|---|
| JCAP | Jefferson Capital Inc | $1.06B | Financial Services | Credit Services | 0.67 |
| MENS | Jyong Biotech Ltd | $174M | Healthcare | Biotechnology | 0.66 |
| AGH | Aureus Greenway Holdings Inc | $87M | Consumer Cyclical | Leisure | 0.64 |
| EMPG | Empro Group Inc | $139M | Healthcare | Medical Distribution | 0.64 |
| CTNM | Contineum Therapeutics Inc - Class A | $546M | Healthcare | Biotechnology | 0.62 |
| BODI | The Beachbody Company Inc Class A | $79M | Communication Services | Internet Content & Information | 0.57 |
| JBS | JBS N.V. - Class A | $13B | Consumer Defensive | Packaged Foods | 0.56 |
| PVLA | Palvella Therapeutics Inc | $2.18B | Healthcare | Biotechnology | 0.56 |
| VWAV | VisionWave Holdings Inc | $85M | Industrials | Aerospace & Defense | 0.56 |
| CICB | CION Investment Corporation 7.50 Notes due 2029 | $1.26B | N/A | N/A | 0.53 |
| PCCT | Spectaire Holdings Inc - Class A | $49M | N/A | N/A | 0.51 |
| ACGLN | Arch Capital Group Ltd | $15B | Financial Services | Insurance - Diversified | 0.50 |
| CTKB | Cytek BioSciences Inc | $601M | Healthcare | Medical Devices | 0.50 |
| CAI | Caris Life Sciences Inc - Class A | $4.94B | Healthcare | Biotechnology | 0.50 |
| RMMZ | RiverNorth Managed Duration Municipal Income Fund II Inc | $126M | Financial Services | Asset Management | 0.50 |
| LSBK | Lake Shore Bancorp Inc | $134M | Financial Services | Banks - Regional | 0.50 |
| PLBL | Polibeli Group Ltd | $2.84B | Consumer Cyclical | Department Stores | 0.50 |
| SCCE | Sachem Capital Corp | $1.18B | N/A | N/A | 0.50 |
| SCCG | Sachem Capital Corp | $1.19B | N/A | N/A | 0.50 |
| BTAI | BioXcel Therapeutics Inc | $25M | Healthcare | Drug Manufacturers - Specialty & Generic | 0.49 |
| PACX | Pioneer Merger Corp - Class A | $513M | N/A | N/A | 0.49 |
| NETD | Nabors Energy Transition Corp II - Class A | $73M | Financial Services | Shell Companies | 0.49 |
| APAD | Enhanced Group Inc - Class A | $161M | Financial Services | Shell Companies | 0.49 |
| HIT | Health In Tech Inc - Class A | $60M | Technology | Software - Application | 0.48 |
| STTK | Shattuck Labs Inc | $512M | Healthcare | Biotechnology | 0.48 |
| FOLD | Amicus Therapeutics Inc | $4.50B | Healthcare | Biotechnology | 0.48 |
| CCCC | C4 Therapeutics Inc | $395M | Healthcare | Biotechnology | 0.48 |
| SOJF | Southern Company | $28B | N/A | N/A | 0.47 |
| DYN | Dyne Therapeutics Inc | $3.96B | Healthcare | Biotechnology | 0.47 |
| NOEMR | CO2 Energy Transition Corp | $416K | N/A | N/A | 0.47 |
| ZIMV | ZimVie Inc | $532M | Healthcare | Medical Devices | 0.47 |
| SNGX | Soligenix Inc | $3.91M | Healthcare | Biotechnology | 0.46 |
| RHLD | Resolute Holdings Management Inc | $1.12B | Industrials | Specialty Business Services | 0.46 |
| TLS | Telos Corp | $361M | Technology | Software - Infrastructure | 0.46 |
| PARAP | Paramount Global Conv Pfd | $8.99B | N/A | N/A | 0.46 |
| MSGY | Masonglory Ltd | $5.30M | Industrials | Engineering & Construction | 0.45 |
| KLRS | Kalaris Therapeutics Inc | $111M | Healthcare | Biotechnology | 0.45 |
| DSGN | Design Therapeutics Inc | $844M | Healthcare | Biotechnology | 0.45 |
| KYMR | Kymera Therapeutics Inc | $9.38B | Healthcare | Biotechnology | 0.45 |
| PRLD | Prelude Therapeutics Inc | $368M | Healthcare | Biotechnology | 0.45 |
| GNL-P-D | Global Net Lease Inc | $5.06B | N/A | N/A | 0.44 |
| NPB | Northpointe Bancshares Inc | $636M | Financial Services | Banks - Regional | 0.44 |
| SCCF | Sachem Capital Corp | $1.18B | N/A | N/A | 0.44 |
| HLLY | Holley Inc - Class A | $309M | Consumer Cyclical | Auto Parts | 0.44 |
| GLIBK | GCI Liberty Inc | $877M | Communication Services | Telecom Services | 0.44 |
| NWTG | Newton Golf Company | $4.59M | Consumer Cyclical | Leisure | 0.43 |
| GBIO | Generation Bio Company | $36M | Healthcare | Biotechnology | 0.43 |
| FHTX | Foghorn Therapeutics Inc | $320M | Healthcare | Biotechnology | 0.43 |
| RKT | Rocket Companies Inc Class A | $41B | Financial Services | Mortgage Finance | 0.43 |
| STRW | Strawberry Fields Reit Inc | $183M | Real Estate | Reit - Healthcare Facilities | 0.43 |
| CLLS | Cellectis | $282M | Healthcare | Biotechnology | 0.43 |
| NRIX | Nurix Therapeutics Inc | $2.47B | Healthcare | Biotechnology | 0.43 |
| STGW | Stagwell Inc - Class A | $1.90B | Communication Services | Advertising Agencies | 0.43 |
| KURA | Kura Oncology Inc | $1.01B | Healthcare | Biotechnology | 0.43 |
| DUKB | Duke Energy Corp | $18B | N/A | N/A | 0.43 |
| SABRP | Sabre Corp | $24B | N/A | N/A | 0.43 |
| YMAB | Y-Mabs Therapeutics Inc | $390M | Healthcare | Biotechnology | 0.43 |
| CGABL | Carlyle Finance LLC | $16B | N/A | N/A | 0.43 |
| GCT | GigaCloud Technology Inc - Class A | $1.37B | Technology | Software - Infrastructure | 0.42 |
| CBL | CBL& Associates Properties Inc - New | $1.64B | Real Estate | Reit - Retail | 0.42 |